Use of Neoadjuvant Vandetanib in Aggressive Pediatric Medullary Thyroid Carcinoma.
Ronik KothariSara KreimerHelen Ruth NadelHilary SeeleyGary HartmanKara S MeisterPublished in: JCO precision oncology (2024)
Novel use of vandetanib in a child with aggressive MTC with prolonged response to treatment.